1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Amexdrug Corporation

Amexdrug Corporation

AXRX
Amexdrug CorporationUS flagOther OTC
0.00
USD
- -
- -
33,882.00Market Cap
2001 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
TTM
Revenue per Share
- -
- -
0.14
0.07
0.04
0.03
0.03
0.04
0.03
0.06
0.07
0.07
0.05
0.05
Basic EPS, GAAP
-0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.05
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
-0.05
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
161
161
161
168
169
169
169
169
169
169
169
169
Sales/Revenue/Turnover
- -
- -
22
12
7
5
5
6
6
10
11
12
9
9
Operating Margin (%)
- -
- -
-0.05
0.28
-0.28
0.26
0.43
-1.56
0.59
0.57
2.53
1.78
2.14
3.61
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
6.82
- -
- -
- -
29.29
27.85
32.57
28.88
46.16
48.63
42.03
Profit Margin (%)
- -
- -
-0.08
0.21
0.16
0.29
0.46
0.19
0.22
0.19
1.65
0.81
0.9
1.81
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Return on Invested Capital (%)
- -
- -
- -
-164.37
- -
- -
- -
-45.5
11.35
11.63
36.81
14.02
7.95
14.81
Return on Capital (%)
- -
- -
- -
-93.5
- -
- -
- -
25.13
18.87
14.36
46.06
13.82
7.56
16.21
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
32.53
17.05
28.16

Capital Structure

FRC

•

in mil. unless spec.
Dec'12
Mar'13
Jun'13
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
169
169
169
Market Capitalization
8
39
25

Working Capital

FRC

•

in mil. unless spec.
Dec'12
Mar'13
Jun'13
Total Current Assets
2
2
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
1
1
1
Total Current Liabilities
2
1
1
Payables & Accruals
1
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
51.46%
80.42%
23.26%
Free Cash Flow
-85.65%
-138.07%
245.12%
Net Income, GAAP
66.4%
184.38%
-18.49%
Sales/Revenue/Turnover
-2.62%
12.73%
-26.26%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
3
4
3
3
12
2012
2
2
2
2
9
2013
2
2
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Jack Amin
Full Time Employees
9
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
7251 Condor Street Commerce CA United States of America 90040
IPO Date
Mar 29, 2001
Website
amexdrug.com
Similar Companies
Harbin Pharmaceutical Group Co., Ltd. (600664.SS)
Pharmadrug Inc. (PHRX.CN)
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
Alar Pharmaceuticals Inc. (6785.TWO)
Karo Pharma AB (publ) (KARO.ST)
Enzychem Lifesciences Corporation (183490.KQ)
Business
Amexdrug Corporation (AXRX), a vertically integrated pharmaceutical and cosmeceutical company founded in 1963 and headquartered in Commerce, California, primarily distributes prescription and over-the-counter drugs, non-drug products, cosmetics, medical devices, nutritional supplements, and health and beauty products through its subsidiaries to independent pharmacies, small chain pharmacies, hospitals, clinics, laboratories, universities, veterinary hospitals and clinics, doctors' offices, and other healthcare providers, predominantly in California. The company operates across two main segments, Distribution and Health and Beauty Products, with eight key business units including Allied Med Wholesale Drug Company, Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan, and BioRx Labels; these units handle research, development, manufacturing, private labeling, and sales of specialized healthcare solutions such as pharmaceuticals, cosmeceuticals, and medical products emphasizing cost-efficiency and quality for smaller providers. Amexdrug engages in strategic acquisitions to expand its portfolio, notably the acquisition of Dermagen Inc. to enhance profit margins through integrated dermatological and cosmeceutical offerings, while maintaining its focus on high-quality, competitively priced products without reported major funding rounds, new product launches, or operational reorganizations in the last one to two years.